bioRxiv Science⌕ Search

Biology subjects

CHENAL, A.

Publications and source records attributed to CHENAL, A..

2 recordsLinked to original sources

B2LiVe, a label-free 1D-NMR method to quantify the binding of amphitropic peptides or proteins to membrane vesicles

Amphitropic proteins and peptides reversibly partition from solution to membrane, a key process that regulates their functions. Experimental approaches, such as fluorescence and circular dichroism, are classically used to measure the partitioning of amphitropic peptides and proteins into lipid bilayers, yet hardly usable when the peptides or proteins do not exhibit significant polarity and/or conformational changes upon membrane binding. Here, we describe B2LiVe (i.e., Binding to Lipid Vesicles), a simple, robust, and widely applicable NMR method to determine the solution-to-membrane partitioning of unlabeled proteins or peptides. The experimental strategy proposed here relies on previously described proton 1D NMR fast pulsing techniques with selective adiabatic pulses. Membrane partitioning induces a large line broadening leading to a progressive loss of protein signals, and therefore, the decrease of the NMR signal directly measures the fraction of membrane-bound protein. The B2LiVe method uses low polypeptide concentrations and has been validated on several membrane-interacting peptides and proteins, ranging from 3 to 54 kDa, with membrane vesicles of different sizes and various lipid compositions. MotivationCharacterization of the interaction of peptides and proteins with lipid membranes is involved in various biological processes and is often challenging for polypeptides which do not possess intrinsic fluorophores, do not exhibit significant structural content changes, as well as for those characterized by low affinities for membranes. To meet these challenges, we have developed a simple and robust label-free NMR-based experimental approach, named B2LiVe, to measure the binding of polypeptides to lipid vesicles. The experimental strategy relies on previously described proton 1D NMR fast pulsing techniques with selective adiabatic pulses to excite the amide resonances. B2LiVe is a label-free method based on the observation of amide hydrogen nuclei which are naturally present in all protein and peptide backbones. Our results validate the B2LiVe method and indicate that it compares well with established technics to quantify polypeptide-membrane interactions. Overall, B2LiVe should efficiently complement the arsenal of label-free biophysical assays available to characterize protein-membrane interactions. In briefWe describe a robust label-free NMR-based experimental approach (B2LiVe) to measure interactions between peptides or proteins with membranes. The validity of this approach has been established on several polypeptides and on various membrane vesicles. The B2LiVe method efficiently complements the arsenal of label-free biophysical techniques to characterize protein-membrane interactions. HighlightsB2LiVe is a simple and robust NMR-based method to quantify affinity of proteins and peptides for membranes B2LiVe is a label-free approach that relies on proton 1D NMR fast pulsing techniques with selective excitation of amide resonances B2LiVe has been validated on several membrane-interacting peptides and proteins B2LiVe coupled to DOSY can pinpoint the presence within a membrane-bound protein of polypeptide segments remaining in solution

biophysics↗

Dynamics and structural changes of calmodulin upon interaction with its potent antagonist calmidazolium

Calmodulin (CaM) is a eukaryotic multifunctional, calcium-modulated protein that regulates the activity of numerous effector proteins involved in a variety of physiological processes. Calmidazolium (CDZ) is a potent small molecule antagonist of CaM and one the most widely used inhibitors of CaM in cell biology. Here, we report the structural characterization of CaM:CDZ complexes using combined SAXS, X-ray crystallography, HDX-MS and NMR approaches. Our results provide molecular insights into the CDZ-induced dynamics and structural changes of CaM leading to its inhibition. CDZ-binding induces an open-to-closed conformational change of CaM and results in a strong stabilization of its structural elements associated with a reduction of protein dynamics over a large time range. These CDZ-triggered CaM changes mimic those induced by CaM-binding peptides derived from protein targets, despite their distant chemical nature. CaM residues in close contact with CDZ and involved in the stabilization of the CaM:CDZ complex have been identified. These results open the way to rationally design new CaM-selective drugs. Figure and text for the Table of Contents (ToC) O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=127 SRC="FIGDIR/small/474921v1_ufig1.gif" ALT="Figure 1"> View larger version (40K): org.highwire.dtl.DTLVardef@b0c76org.highwire.dtl.DTLVardef@15f462forg.highwire.dtl.DTLVardef@1f8e57forg.highwire.dtl.DTLVardef@1a33575_HPS_FORMAT_FIGEXP M_FIG C_FIG Calmidazolium is a potent and widely used inhibitor of calmodulin, a major mediator of calcium-signaling in eukaryotic cells. Structural characterization of calmidazolium-binding to calmodulin reveals that it triggers open-to-closed conformational changes similar to those induced by calmodulin-binding peptides derived from enzyme targets. These results open the way to rationally design new and more selective inhibitors of calmodulin.

biophysics↗